New Targeted Glue Technology Opens Doors to “Undruggable” Proteins
Researchers have developed a novel targeted glue technology that selectively degrades the BRD9 protein. This approach represents a third generation of protein degradation therapeutics beyond PROTACs. The discovery could unlock treatments for cancers and other diseases involving previously undruggabl